Zhao et al. found that Twist1 was an independent factor affecting the pathological response to neoadjuvant chemotherapy for gastric cancer, and the expression of FAP in CAF was a significant factor for poor prognosis in patients with gastric cancer (Tong et al., 2022; Zhao and Zhu, 2023). The gene discussed is TWIST1; the disease is gastric cancer.